Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Wilson

Showing results (71-80 of 258) with videos related to

Pageof 26
Sort By:
Cancer Biology & Therapy|April 21, 2010
The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21Deok-Soo Son, Andrew J Wilson, Angelika K Parl, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2011
Cellular uptake of highly-functionalized ruthenium(II) tris-bipyridine protein-surface mimeticsSusan J Turrell, Maria H Filby, Adrian Whitehouse, et al.
Organic & Biomolecular Chemistry|May 22, 2012
Design, synthesis and binding studies of a novel quadruple ADDA hydrogen-bond arrayMaria L Pellizzaro, Simon A Barrett, Julie Fisher, et al.
European Journal of Biochemistry|July 24, 2002
Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunitBrian A Perrino, Andrew J Wilson, Patricia Ellison, et al.
Journal of Ovarian Research|July 29, 2015
Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancerAndrew J Wilson, Jeanette Saskowski, Whitney Barham, et al.
Gynecologic Oncology|March 18, 2014
Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancerPanagiotis A Konstantinopoulos, Andrew J Wilson, Jeanette Saskowski, et al.
Australian and New Zealand Journal of Public Health|December 18, 2007
Clients' perspective on service quality for type 2 diabetes in AustraliaJafar S Tabrizi, Andrew J Wilson, Eleanor T Coyne, et al.
Organic & Biomolecular Chemistry|July 20, 2011
Ditopic triply hydrogen-bonded heterodimersAdam Gooch, Simon Barrett, Julie Fisher, et al.
Analytical Chemistry|July 4, 2012
Covalent cross-linking within supramolecular peptide structuresGeorge W Preston, Sheena E Radford, Alison E Ashcroft, et al.
Gynecologic Oncology|September 27, 2012
Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancerAndrew J Wilson, Anum S Lalani, Erika Wass, et al.
Pageof 26

Showing results (71-80 of 258) with videos related to

Sort By:
Pageof 26
Cancer Biology & Therapy|April 21, 2010
The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21Deok-Soo Son, Andrew J Wilson, Angelika K Parl, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2011
Cellular uptake of highly-functionalized ruthenium(II) tris-bipyridine protein-surface mimeticsSusan J Turrell, Maria H Filby, Adrian Whitehouse, et al.
Organic & Biomolecular Chemistry|May 22, 2012
Design, synthesis and binding studies of a novel quadruple ADDA hydrogen-bond arrayMaria L Pellizzaro, Simon A Barrett, Julie Fisher, et al.
European Journal of Biochemistry|July 24, 2002
Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunitBrian A Perrino, Andrew J Wilson, Patricia Ellison, et al.
Journal of Ovarian Research|July 29, 2015
Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancerAndrew J Wilson, Jeanette Saskowski, Whitney Barham, et al.
Gynecologic Oncology|March 18, 2014
Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancerPanagiotis A Konstantinopoulos, Andrew J Wilson, Jeanette Saskowski, et al.
Australian and New Zealand Journal of Public Health|December 18, 2007
Clients' perspective on service quality for type 2 diabetes in AustraliaJafar S Tabrizi, Andrew J Wilson, Eleanor T Coyne, et al.
Organic & Biomolecular Chemistry|July 20, 2011
Ditopic triply hydrogen-bonded heterodimersAdam Gooch, Simon Barrett, Julie Fisher, et al.
Analytical Chemistry|July 4, 2012
Covalent cross-linking within supramolecular peptide structuresGeorge W Preston, Sheena E Radford, Alison E Ashcroft, et al.
Gynecologic Oncology|September 27, 2012
Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancerAndrew J Wilson, Anum S Lalani, Erika Wass, et al.
Pageof 26